Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RiaSTAP vs Platelets in Valve Replacement Surgery
NCT01283321Phase 2Terminated
- Sponsor
- Emory University
- Start
- Jan 2011
- Primary completion
- May 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Fibrinogen human in postoperative hemorrhage (2 arms), sponsored by Emory University. Primary endpoints: Hemostatic condition of the surgical field and 24-hour total of blood product transfusion. Started Jan 2011; status: terminated.
02
Drugs
Fibrinogen human
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT01283321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283321.